KETOCONAZOLE

被引：30

作者：

HUME, AL ^{[1
]}

KERKERING, TM ^{[1
]}

机构：

[1] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV INFECT DIS, RICHMOND, VA 23298 USA

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1983年 / 17卷 / 03期

关键词：

D O I：

10.1177/106002808301700301

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：169 / 174

页数：6

共 48 条

[41]

SHADOMY S, 1981, 21ST INT C ANT AG CH

[42] KETOCONAZOLE EFFECTS [J].

STEVENS, DA ;

WILLIAMS, PL ;

SUGAR, AM ;

PONT, A .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (02) :284-285

[43]

SYMOENS J, 1980, REV INFECT DIS, V2, P674

[44]

SYMOENS J, 1981, DIAGNOSIS THERAPY SY

[45]

THIENPONT D, 1980, REV INFECT DIS, V2, P570

[46] INVITRO AND INVIVO EFFECTS OF THE ANTI-MYCOTIC DRUG KETOCONAZOLE ON STEROL SYNTHESIS [J].

VANDENBOSSCHE, H ;

WILLEMSENS, G ;

COOLS, W ;

CORNELISSEN, F ;

LAUWERS, WF ;

VANCUTSEM, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (06) :922-928

[47] THE INFLUENCE OF GASTRIC-ACIDITY ON THE BIO-AVAILABILITY OF KETOCONAZOLE [J].

VANDERMEER, JWM ;

KEUNING, JJ ;

SCHEIJGROND, HW ;

HEYKANTS, J ;

VANCUTSEM, J ;

BRUGMANS, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 (04) :552-554

[48]

WELSH O, 1980, REV INFECT DIS, V2, P582

← 1 2 3 4 5 →